HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.18
Day range
$1.18 - $1.20
Year range
$0.59 - $6.97
Market cap
84.90M USD
Avg Volume
269.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.77M | 47.99% |
Operating expense | 4.75M | -42.86% |
Net income | -10.99M | 62.85% |
Net profit margin | -397.18 | 74.90% |
Earnings per share | -0.15 | 64.29% |
EBITDA | -12.61M | 62.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 111.09M | -7.25% |
Total assets | 161.07M | -31.65% |
Total liabilities | 27.25M | -51.25% |
Total equity | 133.82M | — |
Shares outstanding | 71.34M | — |
Price to book | 0.63 | — |
Return on assets | -18.88% | — |
Return on capital | -22.43% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -10.99M | 62.85% |
Cash from operations | -12.32M | 40.34% |
Cash from investing | -674.00K | 96.57% |
Cash from financing | -11.00K | -100.04% |
Net change in cash | -13.01M | 4.16% |
Free cash flow | -8.46M | 7.99% |
About
Founded
2012
Website
Employees
89
